Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome

NCT06261502 is registered in ClinicalTrials.gov with Université de Sherbrooke as lead sponsor.

NCT NCT06261502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06261502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals With Fragile-X Syndrome
Lead sponsor
Université de Sherbrooke
Phase
Phase 2
Overall status
Recruiting
Start date
September 1, 2025
Completion date
December 1, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fragile x syndrome